AV
Anteris Technologies Global Corp
AVR—
Anteris Technologies Global Corp AI Insights
Informational only. Not investment advice.Snapshot
- Cash burn of 79.4M TTM FCF vs 9.1M cash on hand = ~1.4 months runway without capital raise[Free Cash Flow TTM]
- R&D spend of 62.9M TTM is 29x revenue (2.1M) - pre-commercial biotech with no path to profitability visible[Research and Development TTM]
- P/S of 89.7x vs industry median 4.1x - priced for blockbuster success despite minimal revenue[Price to Sales Ratio]
Watch Triggers
- Cash and Equivalents: Falls below 5M or capital raise announced — Signals imminent dilution; terms will indicate market confidence in pipeline
- Total Revenue TTM: Exceeds 10M quarterly run-rate — Would indicate commercial launch success and path to reduced cash burn
- Research and Development TTM: Declines >20% without revenue growth — Could signal pipeline setback or forced cost cuts from funding constraints
Bull Case
Gross margin of 68% TTM shows product viability if commercialization succeeds; medical device with high-margin potential
Gross Margin TTMGross Profit TTM
Low debt/equity of 0.64 and minimal interest expense (71K) preserves equity financing optionality
Debt to EquityInterest Expense TTM
Bear Case
Cash runway under 2 months at current burn; equity of 3.7M could be wiped by single quarter losses of 21M
Cash and EquivalentsFree Cash Flow TTMTotal Equity
Revenue declined (gross profit -6% YoY) while burning 79M - no commercial traction despite R&D spend
Gross Profit 1Y GrowthTotal Revenue TTM
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
20%
Leverage AVR's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Imminent dilution or debt raise required within 6 months to fund operations
3-12mhigh
- Cash of 9.1M vs quarterly burn rate ~20M
- No revenue scale to fund 62.9M annual R&D
- Negative working capital of -2.2M
FCF TTM: -79.4MCash: 9.1M (down from 28.4M)Current liabilities 13.4M vs current assets 11.2M
Valuation Context
Caveats
Public Strategies Rankings
See how Anteris Technologies Global Corp ranks across different investment strategies.
Leverage AVR's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
AVR Fundamentals
Manufacturing → Chemical Manufacturing
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$221.78M | — | ||
$215.02M | — | ||
0.00 | — | ||
$2.14M | — | ||
$-2.64 | — | ||
-4,042% | — | ||
-3,942% | — | ||
$-79.44M | — | ||
-23 | — | ||
Beta 5Y (Monthly) | unknown | — |
AVR Dividend History
No dividends
AVR Stock Splits
No stock splits
AVR SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/12/25 | 09/30/25 | 10-Q | |
08/11/25 | 06/30/25 | 10-Q | |
05/13/25 | 03/31/25 | 10-Q | |
12/31/24 | 12/31/24 | 10-K | |
09/30/24 | 09/30/24 | Unknown | -- |
06/30/24 | 06/30/24 | Unknown | -- |
03/31/24 | 03/31/24 | Unknown | -- |
12/31/23 | 12/31/23 | Unknown | -- |
09/30/23 | 09/30/23 | Unknown | -- |
06/30/23 | 06/30/23 | Unknown | -- |
03/31/23 | 03/31/23 | Unknown | -- |
12/31/22 | 12/31/22 | Unknown | -- |
09/30/22 | 09/30/22 | Unknown | -- |
06/30/22 | 06/30/22 | Unknown | -- |
03/31/22 | 03/31/22 | Unknown | -- |
12/31/21 | 12/31/21 | Unknown | -- |
09/30/21 | 09/30/21 | Unknown | -- |
06/30/21 | 06/30/21 | Unknown | -- |
03/31/21 | 03/31/21 | Unknown | -- |
12/31/20 | 12/31/20 | Unknown | -- |
09/30/20 | 09/30/20 | Unknown | -- |
06/30/20 | 06/30/20 | Unknown | -- |
03/31/20 | 03/31/20 | Unknown | -- |
12/31/19 | 12/31/19 | Unknown | -- |
09/30/19 | 09/30/19 | Unknown | -- |
06/30/19 | 06/30/19 | Unknown | -- |
03/31/19 | 03/31/19 | Unknown | -- |
12/31/18 | 12/31/18 | Unknown | -- |
09/30/18 | 09/30/18 | Unknown | -- |
06/30/18 | 06/30/18 | Unknown | -- |
03/31/18 | 03/31/18 | Unknown | -- |
12/31/17 | 12/31/17 | Unknown | -- |
09/30/17 | 09/30/17 | Unknown | -- |
06/30/17 | 06/30/17 | Unknown | -- |
03/31/17 | 03/31/17 | Unknown | -- |
12/31/16 | 12/31/16 | Unknown | -- |
09/30/16 | 09/30/16 | Unknown | -- |
06/30/16 | 06/30/16 | Unknown | -- |
03/31/16 | 03/31/16 | Unknown | -- |
12/31/15 | 12/31/15 | Unknown | -- |
09/30/15 | 09/30/15 | Unknown | -- |
06/30/15 | 06/30/15 | Unknown | -- |
03/31/15 | 03/31/15 | Unknown | -- |
12/31/14 | 12/31/14 | Unknown | -- |
09/30/14 | 09/30/14 | Unknown | -- |
06/30/14 | 06/30/14 | Unknown | -- |
03/31/14 | 03/31/14 | Unknown | -- |
12/31/13 | 12/31/13 | Unknown | -- |
09/30/13 | 09/30/13 | Unknown | -- |
06/30/13 | 06/30/13 | Unknown | -- |
03/31/13 | 03/31/13 | Unknown | -- |
12/31/12 | 12/31/12 | Unknown | -- |
09/30/12 | 09/30/12 | Unknown | -- |
06/30/12 | 06/30/12 | Unknown | -- |
03/31/12 | 03/31/12 | Unknown | -- |
12/31/11 | 12/31/11 | Unknown | -- |
09/30/11 | 09/30/11 | Unknown | -- |
06/30/11 | 06/30/11 | Unknown | -- |
03/31/11 | 03/31/11 | Unknown | -- |
12/31/10 | 12/31/10 | Unknown | -- |
09/30/10 | 09/30/10 | Unknown | -- |
06/30/10 | 06/30/10 | Unknown | -- |
03/31/10 | 03/31/10 | Unknown | -- |
12/31/09 | 12/31/09 | Unknown | -- |
09/30/09 | 09/30/09 | Unknown | -- |
06/30/09 | 06/30/09 | Unknown | -- |
03/31/09 | 03/31/09 | Unknown | -- |
12/31/08 | 12/31/08 | Unknown | -- |
09/30/08 | 09/30/08 | Unknown | -- |
06/30/08 | 06/30/08 | Unknown | -- |
03/31/08 | 03/31/08 | Unknown | -- |
12/31/07 | 12/31/07 | Unknown | -- |
09/30/07 | 09/30/07 | Unknown | -- |
06/30/07 | 06/30/07 | Unknown | -- |
03/31/07 | 03/31/07 | Unknown | -- |
12/31/06 | 12/31/06 | Unknown | -- |
09/30/06 | 09/30/06 | Unknown | -- |
06/30/06 | 06/30/06 | Unknown | -- |
03/31/06 | 03/31/06 | Unknown | -- |
12/31/05 | 12/31/05 | Unknown | -- |
09/30/05 | 09/30/05 | Unknown | -- |
06/30/05 | 06/30/05 | Unknown | -- |
12/31/04 | 12/31/04 | Unknown | -- |
09/30/04 | 09/30/04 | Unknown | -- |
06/30/04 | 06/30/04 | Unknown | -- |